Raven biosciences ApS: Financial statements 2019
CVR: 39085127
Source: annual report 2019, Danish Business Authority
01/01/2019 – 31/12/2019
Raven biosciences ApS (CVR 39085127) has filed annual accounts for 2019. In 2019, the company reported revenue of DKK 4,787,235 and a net result of DKK 412,749. The profit margin was 8.6%. Equity in the 2019 report amounted to DKK 668,513. The solvency ratio was 59.6%.
- Revenue
- DKK 4,787,235
- Gross Profit
- DKK 3,425,028
- Profit/Loss
- DKK 412,749
- Equity
- DKK 668,513
- Total Assets
- DKK 1,122,048
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
Raven biosciences ApS has published its interim report for the period November 9, 2017 – December 31, 2018.
About Raven biosciences ApS
Raven biosciences ApS is a Danish company of the type Anpartsselskab based in Aarhus N, founded in 2017. The company is registered under the industry Computerkonsulentbistand og forvaltning af computerfaciliteter. The management consists of Kenneth Graabek Johansen and Roald Forsberg. The company's owners include Kenneth Graabek Johansen, Roald Forsberg and KGJ Invest ApS. The company has 7 employees (2026). In 2025, the company reported revenue of DKK 6,977,057 and a net result of DKK 1,065,066 compared with DKK -925,200 the year before. Equity in the 2025 report amounted to DKK 2,861,815.